Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells
Camilla Pecoraro, Barbara Parrino, Stella Cascioferro, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 19-19
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
Motahareh Mortazavi, Fatemeh Moosavi, Miriam Martini, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103749-103749
Closed Access | Times Cited: 75
A review on the role of cyclin dependent kinases in cancers
Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 70
Oxadiazole: A highly versatile scaffold in drug discovery
Nisheeth C. Desai, Jahnvi D. Monapara, Aratiba M. Jethawa, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 9
Closed Access | Times Cited: 35
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation
Camilla Pecoraro, Michele De Franco, Daniela Carbone, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115134-115134
Closed Access | Times Cited: 33
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma
Daniela Carbone, Michele De Franco, Camilla Pecoraro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3679-3679
Open Access | Times Cited: 29
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma
Daniela Carbone, Michele De Franco, Camilla Pecoraro, et al.
Marine Drugs (2023) Vol. 21, Iss. 5, pp. 288-288
Open Access | Times Cited: 24
Biological Characterization of One Oxadiazole Derivative (5(4‐Hydroxyphenyl)‐2‐(N‐Phenyl Amino)‐1,3,4‐Oxadiazole): In Vitro, In Silico, and Network Pharmacological Approaches
Tuğçe Duran, Irem Balikci, Busra Buyukkosucu, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 1
Closed Access
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1
Daniela Carbone, Camilla Pecoraro, Giovanna Panzeca, et al.
Marine Drugs (2023) Vol. 21, Iss. 7, pp. 412-412
Open Access | Times Cited: 19
Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
Evangelia Sereti, Irida Papapostolou, Konstantinos Dimas
Biomedicines (2023) Vol. 11, Iss. 3, pp. 890-890
Open Access | Times Cited: 14
Marine-Derived Bisindoles for Potent Selective Cancer Drug Discovery and Development
Mengwei Xu, Zhaofang Bai, Baocheng Xie, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 933-933
Open Access | Times Cited: 5
Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 271-289
Closed Access | Times Cited: 4
A comprehensive analysis of the role of molecular docking in the development of anticancer agents against the cell cycle CDK enzyme
PRIYANKA SOLANKI, Nisarg Rana, Prakash C. Jha, et al.
Biocell (2023) Vol. 47, Iss. 4, pp. 707-729
Open Access | Times Cited: 13
Reshaping the Pancreatic Cancer Microenvironment at Different Stages with Chemotherapy
Maozhen Peng, Ying Ying, Zheng Zhang, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2448-2448
Open Access | Times Cited: 11
Anticancer Activity of Thiophene Carboxamide Derivatives as CA-4 Biomimetics: Synthesis, Biological Potency, 3D Spheroid Model, and Molecular Dynamics Simulation
Mohammed Hawash, Mohammed T. Qaoud, Nidal Jaradat, et al.
Biomimetics (2022) Vol. 7, Iss. 4, pp. 247-247
Open Access | Times Cited: 20
Recent Developments on Synthesis Strategies, SAR Studies and Biological Activities of β-Carboline Derivatives – An Update
Ramanjulu Abinaya, Santhanam Srinath, S. Soundarya, et al.
Journal of Molecular Structure (2022) Vol. 1261, pp. 132750-132750
Closed Access | Times Cited: 15
Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors
Bo Yang, Yanni Quan, Wuli Zhao, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 8
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: Synthesis, mechanistic Insights and promising antitumor and safety profile
Daniela Carbone, Camilla Pecoraro, Fabio Scianò, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile
Camilla Pecoraro, Daniela Carbone, Fabio Scianò, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 10, pp. 1278-1294
Open Access | Times Cited: 2
Cyanidin as potential anticancer agent targeting various proliferative pathways
Muhammad Azhaf Safdar, Rana Muhammad Nabeel Aslam, Amna Shakeel, et al.
Chemical Biology & Drug Design (2022) Vol. 101, Iss. 2, pp. 438-452
Closed Access | Times Cited: 12
Synthesis and Anti-Cancer Activity of New Pyrazolinyl-Indole Derivatives: Pharmacophoric Interactions and Docking Studies for Identifying New EGFR Inhibitors
Habibullah Khalilullah, Deepak Agarwal, Mohamed Jawed Ahsan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6548-6548
Open Access | Times Cited: 10
Improving Properties of Podophyllic Aldehyde-Derived Cyclolignans: Design, Synthesis and Evaluation of Novel Lignohydroquinones, Dual-Selective Hybrids against Colorectal Cancer Cells
Ángela‐Patricia Hernández, Paula Díez, Pablo A. García, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 886-886
Open Access | Times Cited: 4
New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4
Dario P. Anobile, Mauro Niso, Adrián Puerta, et al.
Molecules (2022) Vol. 27, Iss. 5, pp. 1682-1682
Open Access | Times Cited: 8
Multi or Single-Kinase Inhibitors to Counteract Drug Resistance in Cancer: What is New?
Camilla Pecoraro, Daniela Carbone, Stella Cascioferro, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 7, pp. 776-782
Closed Access | Times Cited: 8
Nortopsentins as Leads from Marine Organisms for Anticancer and Anti-Inflammatory Agent Development
Camilla Pecoraro, Francesca Terrana, Giovanna Panzeca, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6450-6450
Open Access | Times Cited: 4
Four previously undescribed diketopiperazines from marine fungus Aspergillus puniceus FAHY0085 and their effects on liver X receptor α
Hong Qi, Miaomiao Guo, Jin Yang, et al.
Phytochemistry (2023) Vol. 214, pp. 113816-113816
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top